A recent analysis of SCLC gene expression profiles has clarified four molecular SCLC subtypes driven by global transcription regulators (ASCL1, NEUROD1, POU2F3, and YAP1), which may be the basis for determining SCLC predictive biomarkers (53, 58, 59). The gene discussed is ASCL1; the disease is small cell lung carcinoma.